Addressing Cost Barriers and Enhancing Medicare Access Strategies to Improve Commercialization Strategy

A pharmaceutical manufacturer sought to enhance their product’s commercialization strategy by analyzing patient profiles, the market access landscape, and competitive dynamics. The client was aiming to:

Refine its market access strategy to address affordability challenges
Identify unmet needs in the treatment landscape for recurrent infections

Key Results

Strengthened Market Access Through Medicare Insights

Challenge

A pharmaceutical manufacturer faced challenges in optimizing their product’s commercialization strategy, particularly in addressing affordability barriers and identifying unmet needs for treating recurrent infections. They sought to refine their market access approach and gain deeper insights into patient profiles and competitive dynamics.

Solution

Norstella partnered with the client to deliver actionable insights, leveraging NorstellaLinQ, along with its RWD engagement team, to provide:

Analysis of abandonment patterns and their link to coverage gaps and affordability challenges.
Competitive intelligence highlighting the diminishing effectiveness of alternative therapies in recurrent disease cases.
A roadmap for addressing Medicare payer challenges using claims and market trend data.

Outcome

Norstella’s RWD engagement team translated complex RWD into actionable insights, which helped the client tackle affordability and access challenges in a complex therapeutic area. By addressing barriers to effective treatment adoption, the client not only improved patient outcomes, but also strengthened its market presence in a competitive landscape.

Get Started

Get Closer to the Patient Than Ever Before

NorstellaLinQ links claims, EHR, lab, and electronic prescription data into a single patient view — decision-grade and AI-ready. See what it can do for your team.

Frequently asked questions

Everything You Need to Know

How can real-world data improve a Medicare market access strategy?

Real-world data helps manufacturers identify affordability barriers, analyze coverage gaps, understand patient abandonment patterns and develop data-driven strategies that improve patient access and commercialization.

How did Norstella help improve the client's commercialization strategy?

Norstella used NorstellaLinQ and its real-world data engagement team to analyze patient profiles, market access dynamics and competitive trends, delivering actionable recommendations that strengthened the client’s market access strategy.

Why is analyzing patient abandonment important?

Understanding where and why patients abandon treatment helps manufacturers identify affordability challenges and coverage barriers that can limit treatment adoption and commercial success.

What role does competitive intelligence play in market access?

Competitive intelligence helps manufacturers understand treatment landscape changes, evaluate the effectiveness of alternative therapies and identify opportunities to improve market positioning.

What outcomes did the client achieve?

By translating complex real-world data into actionable insights, the client addressed affordability and access challenges, improved patient outcomes and strengthened its market position within a competitive therapeutic area.